未登录

B

Brian J. Ward

mcgill university health centre

H指数:63

被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Current Applications and Immunological Considerations of Salmonella enterica Serovar Typhimurium as a Vaccine Vector

沙门氏菌肠亚种鼠伤寒血清型作为疫苗载体的当前应用与免疫学考量

IF4.2

2026-02-260

OAAI

Sex-differences in influenza vaccine efficacy and immunogenicity among Canadian Hutterite children

IF3.5

2026-01-210

PRE

Epicutaneous application of house dust mite induces allergic skin inflammation and atopic march to the lung upon airway allergen challenge

经皮应用屋尘螨诱导过敏性皮肤炎症，并在气道过敏原刺激下引发特应性进程至肺部

Clinical Immunology

IF5.7

2025-11-290

PRE

Undernutrition and antibody response to measles, tetanus and Haemophilus Influenzae type b (Hib) vaccination in pre-school south African children: The VHEMBE birth cohort study

营养不良及麻疹、破伤风和Haemophilus Influenzae type b (Hib)疫苗接种后抗体反应：VHEMBE出生队列研究

IF3.5

2025-02-010

PRE

Hemagglutination-Inhibition Antibodies and Protection against Influenza Elicited by Inactivated and Live Attenuated Vaccines in Children

灭活疫苗和减毒活疫苗在儿童中诱导的血凝抑制抗体与抗流感保护作用

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2024-11-060

OAAI

AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans

AS03佐剂增强人类记忆b细胞对基于植物的新型冠状病毒肺炎疫苗反应的幅度，持久性和克隆广度

SCIENCE IMMUNOLOGY

IF16.3

2024-04-055

OA

Multimodal vaccination targeting the receptor binding domains of Clostridioides difficile toxins A and B with an attenuated Salmonella Typhimurium vector (YS1646) protects mice from lethal challenge

MICROBIOLOGY SPECTRUM

IF3.8

2024-02-061

OAAI

Salmonella Typhimurium expressing chromosomally integrated Schistosoma mansoni Cathepsin B protects against schistosomiasis in mice

IF6.5

2023-02-275

OAAI

Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19

IF6.5

2023-02-134

OAAI

Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19

NATURE COMMUNICATIONS

IF15.7

2022-11-126

OAAI

Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities

IF6.5

2022-11-0920

OAAI

Charland, Nathalie; Gobeil, Philipe; Pillet, Stephane; Boulay, Iohann; Seguin, Annie; Makarkov, Alexander; Heizer, Gretchen; Bhutada, Kapil; Mahmood, Asif; Trepanier, Sonia; Hager, Karen; Jiang-Wright, Julia; Atkins, Judith; Saxena, Pooja; Cheng, Matthew P.; Vinh, Donald C.; Boutet, Philippe; Roman, Francois; Van Der Most, Robbert; Ceregido, Maria Angeles; Dionne, Marc; Tellier, Guy; Gauthier, Jean-Sebastien; Essink, Brandon; Libman, Michael; Haffizulla, Jason; Frechette, Andre; D'Aoust, Marc-Andre; Landry, Nathalie; Ward, Brian J.

High Frequency of COVID-19 Vaccine Hesitancy among Canadians Immunized for Influenza: A Cross-Sectional Survey

接种流感疫苗的加拿大人对新型冠状病毒肺炎疫苗犹豫不决的频率很高: 一项横断面调查

IF3.4

2022-09-103

OAAI

Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2022-06-02145

OAAI

Hager, Karen J.; Perez Marc, Gonzalo; Gobeil, Philipe; Diaz, Ricardo S.; Heizer, Gretchen; Llapur, Conrado; Makarkov, Alexander I.; Vasconcellos, Eduardo; Pillet, Stephane; Riera, Fernando; Saxena, Pooja; Geller Wolff, Priscila; Bhutada, Kapil; Wallace, Garry; Aazami, Hessam; Jones, Christine E.; Polack, Fernando P.; Ferrara, Luciana; Atkins, Judith; Boulay, Iohann; Dhaliwall, Jiwanjeet; Charland, Nathalie; Couture, Manon M. J.; Jiang-Wright, Julia; Landry, Nathalie; Lapointe, Sophie; Lorin, Aurelien; Mahmood, Asif; Moulton, Lawrence H.; Pahmer, Emily; Parent, Julie; Seguin, Annie; Tran, Luan; Breuer, Thomas; Ceregido, Maria-Angeles; Koutsoukos, Marguerite; Roman, Francois; Namba, Junya; D'Aoust, Marc-Andre; Trepanier, Sonia; Kimura, Yosuke; Ward, Brian J.

COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab (May, 10.1007/s40120022-00341-z, 2022)

NEUROLOGY AND THERAPY

IF4.8

2022-05-031

OAAI

Cryptococcal Meningitis Reported With Fingolimod Treatment Case Series

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION

IF7.5

2022-05-0110

OAAI

Elimination of receptor binding by influenza hemagglutinin improves vaccine-induced immunity

IF6.5

2022-04-119

OAAI

COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab

NEUROLOGY AND THERAPY

IF4.8

2022-03-1323

OAAI

COVID-19 Infection in Fingolimod- or Siponimod-Treated Patients: Case Series

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION

IF7.5

2022-01-0127

OAAI

Lack of effects on female fertility or pre- and postnatal development of offspring in rats after exposure to AS03-adjuvanted recombinant plant-derived virus-like particle vaccine candidate for COVID-19

REPRODUCTIVE TOXICOLOGY

IF2.8

2022-01-014

OAAI

Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model (vol 13, e0007490, 2019)

PLOS NEGLECTED TROPICAL DISEASES

IF3.4

2021-11-041

OAAI